Schedule 13G ownership disclosure
FUSION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 36118A100
Event date: 2023-12-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.8400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-23-001611
- Form type
- SC 13G
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Dec 18, 2023
- Reporting period
- Dec 14, 2023
- Description
- Schedule 13G beneficial ownership